Lilly Introduces Single-Dose Vials of Zepbound, Expanding Access for Adults with Obesity
The new vials of Zepbound are available through a new self-pay pharmacy channel, priced over 50% lower than other incretin medications for obesity.
The new vials of Zepbound are available through a new self-pay pharmacy channel, priced over 50% lower than other incretin medications for obesity.